FI870160A - Modifierad 2-mikroglobulin och dess antikroppar. - Google Patents

Modifierad 2-mikroglobulin och dess antikroppar. Download PDF

Info

Publication number
FI870160A
FI870160A FI870160A FI870160A FI870160A FI 870160 A FI870160 A FI 870160A FI 870160 A FI870160 A FI 870160A FI 870160 A FI870160 A FI 870160A FI 870160 A FI870160 A FI 870160A
Authority
FI
Finland
Prior art keywords
ser
lys
asp
beta
glu
Prior art date
Application number
FI870160A
Other languages
English (en)
Other versions
FI870160A0 (fi
Inventor
Mogens Holst Nissen
Jesper Zeuthen
Flemming Stig Larsen
Lars Thim
Mogens Christensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI870160A0 publication Critical patent/FI870160A0/fi
Publication of FI870160A publication Critical patent/FI870160A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI870160A 1986-01-16 1987-01-15 Modifierad 2-mikroglobulin och dess antikroppar. FI870160A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK021586A DK160944C (da) 1986-01-16 1986-01-16 Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse

Publications (2)

Publication Number Publication Date
FI870160A0 FI870160A0 (fi) 1987-01-15
FI870160A true FI870160A (fi) 1987-07-17

Family

ID=8091032

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870160A FI870160A (fi) 1986-01-16 1987-01-15 Modifierad 2-mikroglobulin och dess antikroppar.

Country Status (8)

Country Link
US (1) US5051371A (fi)
EP (1) EP0229723A3 (fi)
JP (1) JPS62246596A (fi)
AU (1) AU601963B2 (fi)
DK (1) DK160944C (fi)
FI (1) FI870160A (fi)
NO (1) NO870174L (fi)
PT (1) PT84126B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03500408A (ja) * 1987-09-04 1991-01-31 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 増強された安定性を有するペプチド複合体
FR2735984B1 (fr) * 1995-06-30 1997-09-19 Inst Nat Sante Rech Med Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic
GB9929993D0 (en) * 1999-12-17 2000-02-09 Avidex Ltd Substances
EP1565570A4 (en) * 2002-11-12 2005-12-28 Becton Dickinson Co DIAGNOSIS OF SEPTICEMIA OR SIRS USING BIOMARKER PROFILES
WO2005063335A2 (en) * 2003-12-30 2005-07-14 Statens Serum Institut MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
KR20080006617A (ko) * 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
JP2012242170A (ja) * 2011-05-17 2012-12-10 Tosoh Corp 測定容器

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
JPS5530652A (en) * 1978-08-28 1980-03-04 Seikagaku Kogyo Co Ltd Latex sensitive to antibody of human beta2-microglobulin for quantitizing human beta2-microglobulin and its composite

Also Published As

Publication number Publication date
US5051371A (en) 1991-09-24
FI870160A0 (fi) 1987-01-15
DK21586D0 (da) 1986-01-16
NO870174L (no) 1987-07-17
EP0229723A3 (en) 1990-05-23
AU601963B2 (en) 1990-09-27
DK160944C (da) 1991-10-21
PT84126A (en) 1987-02-01
NO870174D0 (no) 1987-01-15
AU6763987A (en) 1987-07-23
EP0229723A2 (en) 1987-07-22
DK21586A (da) 1987-09-14
PT84126B (pt) 1989-09-14
JPS62246596A (ja) 1987-10-27
DK160944B (da) 1991-05-06

Similar Documents

Publication Publication Date Title
BR0014252A (pt) Nanopartìculas magnéticas tendo atividade bioquìmica, método para sua produção e seus usos
PT87797A (pt) Process for the production of copolymer thickeners in aqueous emulsion with carboxyl-functional soluble in alkalis
EP0004940A1 (de) Verfahren zur radioimmunologischen Bestimmung von Prokollagen (Typ III) und Prokollagen-Peptid (Typ III), zur Herstellung von für das Verfahren geeignetem Prokollagen-Peptid (Typ III) und zur Herstellung von Anti-Prokollagen-Peptid (Typ III)-Serum
DE3855137D1 (de) Verfahren zur Herstellung eines Oxyd-Supraleiters
ATE88716T1 (de) Steroide mit einem 3,4- oder 6-gliedrigen spiroring in stellung 17, ihre herstellung, zwischenprodukte in ihrer herstellung, ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen, die sie enthalten.
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
FI870160A (fi) Modifierad 2-mikroglobulin och dess antikroppar.
ATE7761T1 (de) Impfstoff und herstellungsverfahren.
Kabat et al. Preparation of the type-specific polysaccharide of the type I meningococcus and a study of its effectiveness as an antigen in human beings
DE3668168D1 (de) Desmosinderivate und reagenz zur herstellung artifizieller antigene.
ATE24018T1 (de) Polysaccharid-antigen aus streptococcus und impfstoffe.
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
AU4458785A (en) Production of the E. Coli LT-B entertoxin subunit
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
Coronelli et al. GARDIMYCIN, A NEW ANTIBIOTIC FROM ACTINOPLANES II. ISOLATION AND PRELIMINARY CHARACTERIZATION
KR860007286A (ko) Grf 유도체의 제조방법
SE8901127D0 (sv) Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
Ryser et al. Cell‐mediated immunity to antigens associated with murine sarcoma virus‐induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro
JPS55161801A (en) Fluorescence-labeled acid mucopolysaccharide and preparation thereof
DK479687A (da) Antistoffer mod modificeret beta2-mikroglobulin samt diagnostika og praeparater indeholdende disse
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
DE3231204A1 (de) Antikoerper gegen bakterielle peptidoglycane, verfahren zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
Affronti et al. Some early investigations of Mycobacterium tuberculosis
DE69110495D1 (de) Verfahren zur Herstellung eines oxidischen Supraleiters.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: NOVO NORDISK A/S